Acamprosate Efficacy in Alcohol‐Dependent Patients: Summary of Results from Three Pivotal Trials
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
In 2004, the United States Food and Drug Administration (FDA) approved acamprosate for use in conjunction with psychosocial support in the maintenance of abstinence in alcohol‐dependent patients who are abstinent at treatment initiation. That approval was based primarily on a re‐analysis of three European double‐blind, placebo‐controlled trials in which complete abstinence was the primary outcome measure. The current report presents data from the re‐analysis of the pivotal trials, which were 13‐, 48‐, and 52‐week studies. A total of 998 DSM‐III‐R alcohol‐dependent patients were included in the studies, with the majority abstinent at randomization. Using a more stringent definition of abstinence, re‐analysis of the rate of complete abstinence, percent days abstinent, and the time to first drink confirmed the original findings for the efficacy of acamprosate in the treatment of alcohol dependence. Rate of complete abstinence was significantly higher with acamprosate than placebo (p < .05); both percent days abstinent and time to first drink were also significantly greater among acamprosate‐treated than placebo‐treated patients (p < .01). These findings support the use of acamprosate in the treatment of alcohol dependence and illustrate some of the issues that can arise in the FDA process for approval of medications to treat the disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
&NA; (1988) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-198802020-00022 · Cited by 12,526
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., Rush, A. J., Walters, E. E., & Wang, P. S. (2003) · JAMA · doi:10.1001/jama.289.23.3095 · Cited by 7,988
Anton, R. F., O’Malley, S. S., Ciraulo, D. A., Cisler, R. A., Couper, D., Donovan, D. M., Gastfriend, D. R., Hosking, J. D., Johnson, B. A., LoCastro, J. S., et al. (2006) · JAMA · doi:10.1001/jama.295.17.2003 · Cited by 1,930
Grant, B. F., Dawson, D. A., Stinson, F. S., Chou, S. P., Dufour, M. C., & Pickering, R. P. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.02.004 · Cited by 1,507
National Trends in the Outpatient Treatment of Depression
Olfson, M. (2002) · JAMA · doi:10.1001/jama.287.2.203 · Cited by 847
Carmen, B., Angeles, M., Ana, M., & María, A. J. (2004) · Addiction · doi:10.1111/j.1360-0443.2004.00763.x · Cited by 504
Relapse Prevention by Acamprosate: Results From a Placebo-Controlled Study on Alcohol Dependence
Sass, H. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830080023006 · Cited by 479
Cohen, E., Feinn, R., Arias, A., & Kranzler, H. R. (2007) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2006.06.008 · Cited by 467
Self-citationPharmacological Treatment of Alcohol Dependence: A Review of the Evidence
Garbutt, J. C., West, S. L., Carey, T. S., Lohr, K. N., & Crews, F. T. (1999) · JAMA · doi:10.1001/jama.281.14.1318 · Cited by 444
Johnson, B. A., Roache, J. D., Javors, M. A., DiClemente, C. C., Cloninger, C. R., Prihoda, T. J., Bordnick, P. S., Ait-Daoud, N., & Hensler, J. (2000) · JAMA · doi:10.1001/jama.284.8.963 · Cited by 414
The pharmacological treatment of alcohol dependence.
Swift, R. M. (1997) · PubMed · Cited by 372
Mann, K., Lehert, P., & Morgan, M. Y. (2004) · Alcoholism: Clinical and Experimental Research · doi:10.1097/01.alc.0000108656.81563.05 · Cited by 364
Harwood, H. J. (2000) · Medical Entomology and Zoology · Cited by 295
DOUBLE-BLIND RANDOMIZED MULTICENTRE TRIAL OF ACAMPROSATE IN MAINTAINING ABSTINENCE FROM ALCOHOL
(1995) · Alcohol and Alcoholism · doi:10.1093/oxfordjournals.alcalc.a045720 · Cited by 273
Drug therapy for alcohol dependence
Swift, R. M. (1999) · New England Journal of Medicine · doi:10.1056/nejm199905133401907 · Cited by 255
Friedmann, P. D., McCullough, D., Chin, M. H., & Saitz, R. (2000) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.2000.03379.x · Cited by 232
Kranzler, H. R., Burleson, J. A., Brown, J., & Babor, T. F. (1996) · Alcoholism: Clinical and Experimental Research · doi:10.1111/j.1530-0277.1996.tb01696.x · Cited by 213
Self-citationChick, J. (2000) · Alcohol and Alcoholism · doi:10.1093/alcalc/35.2.176 · Cited by 213
MASON, B., GOODMAN, A., CHABAC, S., & LEHERT, P. (2006) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.02.002 · Cited by 212
FINNEY, J. W., HAHN, A. C., & MOOS, R. H. (1996) · Addiction · doi:10.1046/j.1360-0443.1996.911217733.x · Cited by 207
Neuroprotective and Abstinence-Promoting Effects of Acamprosate: Elucidating the Mechanism of Action
De Witte, P., Littleton, J., Parot, P., & Koob, G. (2005) · CNS Drugs · doi:10.2165/00023210-200519060-00004 · Cited by 201
Pelc, I., Verbanck, P., Bon, O. L., Gavrilovic, M., Lion, K., & Lehert, P. (1997) · British Journal of Psychiatry · doi:10.1192/bjp.171.1.73 · Cited by 184
Acamprosate in alcohol dependence: how does it work?
LITTLETON, J. (1995) · Addiction · doi:10.1111/j.1360-0443.1995.tb01088.x · Cited by 178
Morley, K. C., Teesson, M., Reid, S. C., Sannibale, C., Thomson, C., Phung, N., Weltman, M., Bell, J. R., Richardson, K., & Haber, P. S. (2006) · Addiction · doi:10.1111/j.1360-0443.2006.01555.x · Cited by 165
Regulation of NMDA receptors by ethanol
Kumari, M., & Ticku, M. K. (2000) · Progress in Drug Research · doi:10.1007/978-3-0348-8391-7_5 · Cited by 136
Imbalance between neuroexcitatory and neuroinhibitory amino acids causes craving for ethanol
Witte, P. D. (2004) · Addictive Behaviors · doi:10.1016/j.addbeh.2004.06.020 · Cited by 129
Understanding US addiction physicians' low rate of naltrexone prescription
Mark, T. (2003) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(03)00134-0 · Cited by 120
Physicians’ opinions about medications to treat alcoholism
Mark, T. L., Kranzler, H. R., Song, X., Bransberger, P., Poole, V. H., & Crosse, S. B. (2003) · Addiction · doi:10.1046/j.1360-0443.2003.00377.x · Cited by 119
Self-citationFriedmann, P. D., Saitz, R., & Samet, J. H. (1998) · JAMA · doi:10.1001/jama.279.15.1227 · Cited by 116
Namkoong, K. (2003) · Alcohol and Alcoholism · doi:10.1093/alcalc/agg038 · Cited by 84
Current Pharmacotherapies of Alcoholism: A U.S. Perspective
Anton, R. F., & Swift, R. M. (2003) · The American Journal on Addictions · doi:10.1111/j.1521-0391.2003.tb00496.x · Cited by 65
Acceptance of moderate drinking by alcohol treatment services in the United States.
Rosenberg, H., & Davis, L. A. (1994) · Journal of Studies on Alcohol · doi:10.15288/jsa.1994.55.167 · Cited by 60
Johnson, B. A. (2004) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.5.9.1943 · Cited by 38
The medical complications of alcohol use: understanding mechanisms to improve management
Chase, V., Neild, R., Sadler, C., & Batey, R. G. (2005) · Drug and Alcohol Review · doi:10.1080/09595230500167510 · Cited by 19
Acamprosate for Alcohol Dependence: An Update for the Clinician
Mason, B. J. (2006) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/foc.4.4.505 · Cited by 5
Cited by
Maisel, N. C., Blodgett, J. C., Wilbourne, P. L., Humphreys, K., & Finney, J. W. (2013) · Addiction · doi:10.1111/j.1360-0443.2012.04054.x · Cited by 470
Friedmann, P. D., Hoskinson, R., Gordon, M., Schwartz, R., Kinlock, T., Knight, K., Flynn, P. M., Welsh, W. N., Stein, L. A. R., Sacks, S., et al. (2012) · Substance Abuse · doi:10.1080/08897077.2011.611460 · Cited by 223
Glutamatergic medications for the treatment of drug and behavioral addictions
Olive, M. F., Cleva, R. M., Kalivas, P. W., & Malcolm, R. J. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2011.04.015 · Cited by 210
“…overall alcohol consumption, subjective measures of alcohol craving, and promoting abstinence, as reviewed in recent meta-analyses (Kennedy et al., 2010; Kiefer and Mann, 2010; Kranzler and Gage, 2008; Mann et al., 2008; Mason and Heyser, 2010a, b; Rosner et al., 2010; Snyder and Bowers, 2008).”
BackgroundMethodPharmacotherapy for alcohol dependence: status of current treatments
Franck, J., & Jayaram-Lindström, N. (2013) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2013.05.005 · Cited by 107
Metadata
- Authors
- Kranzler, H. R., & Gage, A.
- Venue
- The American Journal on Addictions
- Publisher
- Wiley
- Published
- 2008-01-02
- Volume
- 17
- Issue
- 1
- Pages
- 70-76
- ISSN
- 1055-0496 (ISSN-L)
- 1521-0391
- OpenAlex
- W2101628508
- Cited by
- 212
- References
- 35
- FWCI
- 5.47
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.